Colinz Laboratories Limited (BOM:531210)
India
· Delayed Price · Currency is INR 41.50
-0.47 (-1.12%)
At close: Mar 10, 2026
Colinz Laboratories Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2020 - 2016 |
| Revenue | 58.4 | 65.28 | 70.3 | 71.55 | 69.74 | 61.59 | Upgrade
|
| Revenue Growth (YoY) | -12.92% | -7.14% | -1.75% | 2.59% | 13.24% | -19.00% | Upgrade
|
| Cost of Revenue | 16.84 | 21.41 | 24.46 | 23.94 | 23.74 | 22.29 | Upgrade
|
| Gross Profit | 41.56 | 43.87 | 45.84 | 47.61 | 46.01 | 39.3 | Upgrade
|
| Selling, General & Admin | 28.87 | 30.27 | 31.34 | 32.2 | 30.34 | 26.58 | Upgrade
|
| Other Operating Expenses | 8.54 | 8.65 | 9.08 | 9.09 | 9.8 | 9.38 | Upgrade
|
| Operating Expenses | 38.92 | 40.23 | 41.72 | 42.57 | 42.16 | 37.88 | Upgrade
|
| Operating Income | 2.63 | 3.64 | 4.13 | 5.04 | 3.85 | 1.42 | Upgrade
|
| Interest Expense | -0.52 | -0.42 | -0.37 | -0.52 | -0.76 | -0.87 | Upgrade
|
| Interest & Investment Income | 2.88 | 2.88 | 2.74 | 1.7 | 1.67 | 1.7 | Upgrade
|
| Other Non Operating Income (Expenses) | 0.98 | 0.1 | 0.01 | 0.02 | 0.04 | 0.2 | Upgrade
|
| EBT Excluding Unusual Items | 5.97 | 6.19 | 6.5 | 6.24 | 4.8 | 2.45 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | - | - | -0.24 | - | - | Upgrade
|
| Pretax Income | 5.97 | 6.19 | 6.5 | 6 | 4.8 | 2.45 | Upgrade
|
| Income Tax Expense | 1.03 | 1.23 | 1.64 | 1.42 | 1.41 | 0.38 | Upgrade
|
| Net Income | 4.94 | 4.97 | 4.87 | 4.57 | 3.39 | 2.08 | Upgrade
|
| Net Income to Common | 4.94 | 4.97 | 4.87 | 4.57 | 3.39 | 2.08 | Upgrade
|
| Net Income Growth | 2.38% | 2.03% | 6.41% | 34.81% | 63.44% | 59.15% | Upgrade
|
| Shares Outstanding (Basic) | 3 | 3 | 3 | 3 | 5 | 5 | Upgrade
|
| Shares Outstanding (Diluted) | 3 | 3 | 3 | 3 | 5 | 5 | Upgrade
|
| Shares Change (YoY) | -0.24% | -0.04% | 0.34% | -45.19% | -0.61% | 0.93% | Upgrade
|
| EPS (Basic) | 1.96 | 1.97 | 1.93 | 1.82 | 0.74 | 0.45 | Upgrade
|
| EPS (Diluted) | 1.96 | 1.97 | 1.93 | 1.82 | 0.74 | 0.45 | Upgrade
|
| EPS Growth | 2.63% | 2.07% | 6.04% | 145.95% | 64.44% | 57.68% | Upgrade
|
| Free Cash Flow | - | -17.16 | 10.35 | 4.03 | 4.3 | 20 | Upgrade
|
| Free Cash Flow Per Share | - | -6.81 | 4.10 | 1.60 | 0.94 | 4.34 | Upgrade
|
| Gross Margin | 71.16% | 67.21% | 65.21% | 66.54% | 65.97% | 63.81% | Upgrade
|
| Operating Margin | 4.50% | 5.58% | 5.87% | 7.04% | 5.52% | 2.30% | Upgrade
|
| Profit Margin | 8.45% | 7.61% | 6.92% | 6.39% | 4.87% | 3.37% | Upgrade
|
| Free Cash Flow Margin | - | -26.28% | 14.72% | 5.63% | 6.16% | 32.48% | Upgrade
|
| EBITDA | 3.95 | 4.95 | 5.43 | 6.33 | 5.86 | 3.33 | Upgrade
|
| EBITDA Margin | 6.76% | 7.58% | 7.72% | 8.84% | 8.40% | 5.41% | Upgrade
|
| D&A For EBITDA | 1.32 | 1.31 | 1.3 | 1.29 | 2.01 | 1.91 | Upgrade
|
| EBIT | 2.63 | 3.64 | 4.13 | 5.04 | 3.85 | 1.42 | Upgrade
|
| EBIT Margin | 4.50% | 5.58% | 5.87% | 7.04% | 5.52% | 2.30% | Upgrade
|
| Effective Tax Rate | 17.23% | 19.83% | 25.16% | 23.74% | 29.36% | 15.33% | Upgrade
|
| Revenue as Reported | 62.25 | 68.26 | 73.05 | 73.27 | 71.45 | 63.5 | Upgrade
|
| Advertising Expenses | - | 0.18 | 0.11 | 0.16 | 0.11 | 0.06 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.